81/100B547.03
USD
4.03
(0.74%)
Pre Open·549.72USD+2.69(+0.49%)
Last updated: · Delayed 15 min
Vertex Pharmaceuticals cash on hand 1990–2026What is a balance sheet? The balance sheet lists what a company owns (assets), what it owes (liabilities) and what is left for its shareholders (equity) on one date.
Vertex Pharmaceuticals had 6.30B USD in cash and short-term investments on 30 September 2026, up 0.3% on a year before. At the end of fiscal year 2025 it had 6.61B USD.
Last updated 9 Nov 2026 · Next report 11 Feb 2027
Cash on hand
Growth
| Fiscal year | Period ending | Cash on hand | Growth | Total debt | Net cash |
|---|---|---|---|---|---|
| Latest quarter | 30 Sept 2026 | 6.30B | +0.26% | 6.48B | -175.10M |
| FY2025 | 31 Dec 2025 | 6.61B | +8.10% | 3.88B | 2.73B |
| FY2024 | 31 Dec 2024 | 6.12B | -45.48% | 1.75B | 4.37B |
| FY2023 | 31 Dec 2023 | 11.22B | +4.08% | 808.40M | 10.41B |
| FY2022 | 31 Dec 2022 | 10.78B | +43.24% | 899.70M | 9.88B |
| FY2021 | 31 Dec 2021 | 7.52B | +13.01% | 967.40M | 6.56B |
| FY2020 | 31 Dec 2020 | 6.66B | +74.85% | 931.90M | 5.73B |
| FY2019 | 31 Dec 2019 | 3.81B | +20.20% | 661.66M | 3.15B |
| FY2018 | 31 Dec 2018 | 3.17B | +51.69% | 586.82M | 2.58B |
| FY2017 | 31 Dec 2017 | 2.09B | +45.60% | 606.43M | 1.48B |
| FY2016 | 31 Dec 2016 | 1.43B | +37.61% | 840.76M | 593.80M |
| FY2015 | 31 Dec 2015 | 1.04B | -24.85% | 826.24M | 216.22M |
| FY2014 | 31 Dec 2014 | 1.39B | -5.32% | 824.95M | 562.16M |
| FY2013 | 31 Dec 2013 | 1.47B | +10.89% | 506.58M | 958.49M |
| FY2012 | 31 Dec 2012 | 1.32B | +36.36% | 696.91M | 624.31M |
| FY2011 | 31 Dec 2011 | 968.92M | -6.06% | 455.95M | 512.97M |
| FY2010 | 31 Dec 2010 | 1.03B | -19.73% | 536.99M | 494.42M |
| FY2009 | 31 Dec 2009 | 1.28B | +54.42% | 185.91M | 1.10B |
| FY2008 | 31 Dec 2008 | 832.10M | +80.55% | 287.50M | 544.60M |
| FY2007 | 31 Dec 2007 | 460.87M | -34.59% | 20.00M | 440.87M |
| FY2006 | 31 Dec 2006 | 704.63M | +95.10% | 123.76M | 580.87M |
| FY2005 | 31 Dec 2005 | 361.16M | -7.94% | 180.10M | 181.06M |
| FY2004 | 31 Dec 2004 | 392.32M | -32.73% | 335.00M | 57.32M |
| FY2003 | 31 Dec 2003 | 583.16M | -8.16% | 363.85M | 219.32M |
| FY2002 | 31 Dec 2002 | 634.98M | -14.56% | 328.14M | 306.85M |
| FY2001 | 31 Dec 2001 | 743.20M | +91.25% | 327.61M | 415.60M |
| FY2000 | 31 Dec 2000 | 388.60M | +1,133.65% | 362.34M | 26.26M |
| FY1999 | 31 Dec 1999 | 31.50M | +30.17% | 7.06M | 24.44M |
| FY1998 | 31 Dec 1998 | 24.20M | -66.15% | 9.80M | 14.40M |
| FY1997 | 31 Dec 1997 | 71.50M | +104.87% | 8.40M | 63.10M |
| FY1996 | 31 Dec 1996 | 34.90M | +22.89% | 8.50M | 26.40M |
| FY1995 | 31 Dec 1995 | 28.40M | -60.34% | 7.00M | 21.40M |
| FY1994 | 31 Dec 1994 | 71.60M | +150.35% | 6.40M | 65.20M |
| FY1993 | 31 Dec 1993 | 28.60M | +146.55% | 6.00M | 22.60M |
| FY1992 | 31 Dec 1992 | 11.60M | -57.97% | 5.10M | 6.50M |
| FY1991 | 31 Dec 1991 | 27.60M | +527.27% | 3.30M | 24.30M |
| FY1990 | 31 Dec 1990 | 4.40M | — | 3.20M | 1.20M |
| Quarter | Period ending | Cash on hand | Growth on a year before | Total debt | Net cash |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 6.30B | +0.26% | 6.48B | -175.10M |
| Q2 FY2026 | 30 Jun 2026 | 7.85B | +23.02% | 1.98B | 5.87B |
| Q1 FY2026 | 31 Mar 2026 | 7.25B | +16.86% | 1.99B | 5.26B |
| Q4 FY2025 | 31 Dec 2025 | 6.61B | +8.10% | 3.88B | 2.73B |
| Q3 FY2025 | 30 Sept 2025 | 6.29B | -3.64% | 1.83B | 4.45B |
| Q2 FY2025 | 30 Jun 2025 | 6.38B | +10.13% | 1.53B | 4.86B |
| Q1 FY2025 | 31 Mar 2025 | 6.20B | -39.03% | 1.65B | 4.55B |
| Q4 FY2024 | 31 Dec 2024 | 6.12B | -45.48% | 1.75B | 4.37B |
| Q3 FY2024 | 30 Sept 2024 | 6.52B | -45.30% | 1.70B | 4.82B |
| Q2 FY2024 | 30 Jun 2024 | 5.80B | -48.42% | 933.40M | 4.86B |
| Q1 FY2024 | 31 Mar 2024 | 10.17B | -2.33% | 721.30M | 9.45B |
| Q4 FY2023 | 31 Dec 2023 | 11.22B | +4.08% | 808.40M | 10.41B |
| Q3 FY2023 | 30 Sept 2023 | 11.93B | +22.08% | 744.70M | 11.18B |
| Q2 FY2023 | 30 Jun 2023 | 11.24B | +21.43% | 767.60M | 10.47B |
| Q1 FY2023 | 31 Mar 2023 | 10.41B | +26.41% | 789.20M | 9.62B |
| Q4 FY2022 | 31 Dec 2022 | 10.78B | +43.24% | 899.70M | 9.88B |
| Q3 FY2022 | 30 Sept 2022 | 9.77B | +40.37% | 824.60M | 8.95B |
| Q2 FY2022 | 30 Jun 2022 | 9.25B | +37.95% | 847.30M | 8.41B |
| Q1 FY2022 | 31 Mar 2022 | 8.24B | +18.98% | 872.50M | 7.37B |
| Q4 FY2021 | 31 Dec 2021 | 7.52B | +13.01% | 967.40M | 6.56B |
| Q3 FY2021 | 30 Sept 2021 | 6.96B | +13.17% | 876.80M | 6.08B |
| Q2 FY2021 | 30 Jun 2021 | 6.71B | +23.07% | 893.85M | 5.81B |
| Q1 FY2021 | 31 Mar 2021 | 6.92B | +65.23% | 898.80M | 6.03B |
| Q4 FY2020 | 31 Dec 2020 | 6.66B | +74.85% | 931.90M | 5.73B |
| Q3 FY2020 | 30 Sept 2020 | 6.15B | +53.92% | 546.51M | 5.60B |
| Q2 FY2020 | 30 Jun 2020 | 5.45B | +37.95% | 522.07M | 4.93B |
| Q1 FY2020 | 31 Mar 2020 | 4.19B | +20.48% | 532.95M | 3.66B |
| Q4 FY2019 | 31 Dec 2019 | 3.81B | +20.20% | 661.66M | 3.15B |
| Q3 FY2019 | 30 Sept 2019 | 4.00B | +30.77% | 604.54M | 3.39B |
| Q2 FY2019 | 30 Jun 2019 | 3.95B | +42.76% | 611.96M | 3.34B |
| Q1 FY2019 | 31 Mar 2019 | 3.48B | +40.41% | 623.87M | 2.85B |
| Q4 FY2018 | 31 Dec 2018 | 3.17B | +51.69% | 586.82M | 2.58B |
| Q3 FY2018 | 30 Sept 2018 | 3.06B | +68.62% | 588.04M | 2.47B |
| Q2 FY2018 | 30 Jun 2018 | 2.77B | +65.87% | 592.74M | 2.18B |
| Q1 FY2018 | 31 Mar 2018 | 2.48B | +75.83% | 595.13M | 1.88B |
| Q4 FY2017 | 31 Dec 2017 | 2.09B | +45.60% | 606.43M | 1.48B |
| Q3 FY2017 | 30 Sept 2017 | 1.81B | +60.60% | 587.19M | 1.23B |
| Q2 FY2017 | 30 Jun 2017 | 1.67B | +55.74% | 568.54M | 1.10B |
| Q1 FY2017 | 31 Mar 2017 | 1.41B | +37.36% | 548.40M | 860.38M |
| Q4 FY2016 | 31 Dec 2016 | 1.43B | +37.61% | 840.76M | 593.80M |
| Q3 FY2016 | 30 Sept 2016 | 1.13B | +12.19% | 820.32M | 308.13M |
| Q2 FY2016 | 30 Jun 2016 | 1.07B | +5.41% | 820.63M | 250.80M |
| Q1 FY2016 | 31 Mar 2016 | 1.03B | -13.17% | 824.49M | 201.12M |
| Q4 FY2015 | 31 Dec 2015 | 1.04B | -24.85% | 826.24M | 216.22M |
| Q3 FY2015 | 30 Sept 2015 | 1.01B | -31.93% | 820.98M | 184.85M |
| Q2 FY2015 | 30 Jun 2015 | 1.02B | -16.63% | 824.47M | 191.98M |
| Q1 FY2015 | 31 Mar 2015 | 1.18B | -10.80% | 833.91M | 347.23M |
| Q4 FY2014 | 31 Dec 2014 | 1.39B | -5.32% | 824.95M | 562.16M |
| Q3 FY2014 | 30 Sept 2014 | 1.48B | +3.87% | 828.24M | 649.50M |
| Q2 FY2014 | 30 Jun 2014 | 1.22B | -14.79% | 538.03M | 681.13M |
| Q1 FY2014 | 31 Mar 2014 | 1.32B | +6.85% | 541.18M | 783.02M |
| Q4 FY2013 | 31 Dec 2013 | 1.47B | +10.89% | 506.58M | 958.49M |
| Q3 FY2013 | 30 Sept 2013 | 1.42B | +9.56% | 446.38M | 976.27M |
| Q2 FY2013 | 30 Jun 2013 | 1.43B | +16.95% | 397.85M | 1.03B |
| Q1 FY2013 | 31 Mar 2013 | 1.24B | +26.35% | 739.88M | 499.48M |
| Q4 FY2012 | 31 Dec 2012 | 1.32B | +36.36% | 696.91M | 624.31M |
| Q3 FY2012 | 30 Sept 2012 | 1.30B | +97.14% | 400.00M | 898.54M |
| Q2 FY2012 | 30 Jun 2012 | 1.22B | +106.13% | 400.00M | 823.33M |
| Q1 FY2012 | 31 Mar 2012 | 980.87M | +19.12% | 400.00M | 580.87M |
| Q4 FY2011 | 31 Dec 2011 | 968.92M | -6.06% | 455.95M | 512.97M |
| Q3 FY2011 | 30 Sept 2011 | 658.69M | -45.25% | 498.42M | 160.27M |
| Q2 FY2011 | 30 Jun 2011 | 593.49M | -39.39% | 494.66M | 98.83M |
| Q1 FY2011 | 31 Mar 2011 | 823.45M | -24.64% | 492.10M | 331.35M |
| Q4 FY2010 | 31 Dec 2010 | 1.03B | -19.73% | 536.99M | 494.42M |
| Q3 FY2010 | 30 Sept 2010 | 1.20B | +40.44% | 487.23M | 715.79M |
| Q2 FY2010 | 30 Jun 2010 | 979.15M | +29.80% | 86.41M | 892.74M |
| Q1 FY2010 | 31 Mar 2010 | 1.09B | +25.71% | 125.32M | 967.37M |
| Q4 FY2009 | 31 Dec 2009 | 1.28B | +54.42% | 185.91M | 1.10B |
| Q3 FY2009 | 30 Sept 2009 | 856.61M | -6.90% | 262.84M | 593.77M |
| Q2 FY2009 | 30 Jun 2009 | 754.36M | -9.34% | 144.00M | 610.36M |
| Q1 FY2009 | 31 Mar 2009 | 869.19M | +15.95% | 287.50M | 581.69M |
| Q4 FY2008 | 31 Dec 2008 | 832.10M | +80.55% | 287.50M | 544.60M |
| Q3 FY2008 | 30 Sept 2008 | 920.07M | +83.08% | 287.50M | 632.57M |
| Q2 FY2008 | 30 Jun 2008 | 832.06M | +40.32% | 287.50M | 544.56M |
| Q1 FY2008 | 31 Mar 2008 | 749.64M | +14.42% | 287.50M | 462.14M |
| Q4 FY2007 | 31 Dec 2007 | 460.87M | -34.59% | 20.00M | 440.87M |
| Q3 FY2007 | 30 Sept 2007 | 502.55M | -27.67% | 20.00M | 482.55M |
| Q2 FY2007 | 30 Jun 2007 | 592.97M | +126.03% | 62.10M | 530.87M |
| Q1 FY2007 | 31 Mar 2007 | 655.14M | +93.00% | 65.23M | 589.91M |
| Q4 FY2006 | 31 Dec 2006 | 704.63M | +95.10% | 123.76M | 580.87M |
| Q3 FY2006 | 30 Sept 2006 | 694.76M | +74.05% | 101.75M | 593.01M |
| Q2 FY2006 | 30 Jun 2006 | 262.34M | -41.26% | 180.09M | 82.25M |
| Q1 FY2006 | 31 Mar 2006 | 339.46M | +1.53% | 180.10M | 159.36M |
| Q4 FY2005 | 31 Dec 2005 | 361.16M | -7.94% | 180.10M | 181.06M |
| Q3 FY2005 | 30 Sept 2005 | 399.17M | -4.60% | 294.55M | 104.62M |
| Q2 FY2005 | 30 Jun 2005 | 446.61M | -2.99% | 335.00M | 111.61M |
| Q1 FY2005 | 31 Mar 2005 | 334.33M | -35.78% | 335.00M | -665.00K |
| Q4 FY2004 | 31 Dec 2004 | 392.32M | -32.73% | 335.00M | 57.32M |
| Q3 FY2004 | 30 Sept 2004 | 418.43M | -29.75% | 319.69M | 98.74M |
| Q2 FY2004 | 30 Jun 2004 | 460.37M | -27.32% | 322.61M | 137.76M |
| Q1 FY2004 | 31 Mar 2004 | 520.57M | -23.46% | 315.04M | 205.54M |
| Q4 FY2003 | 31 Dec 2003 | 583.16M | -8.16% | 363.85M | 219.32M |
| Q3 FY2003 | 30 Sept 2003 | 595.60M | -8.56% | 345.33M | 250.27M |
| Q2 FY2003 | 30 Jun 2003 | 633.40M | -6.83% | 340.78M | 292.62M |
| Q1 FY2003 | 31 Mar 2003 | 680.09M | -2.71% | 329.90M | 350.19M |
| Q4 FY2002 | 31 Dec 2002 | 634.98M | -14.56% | 328.14M | 306.85M |
| Q3 FY2002 | 30 Sept 2002 | 651.35M | +70.57% | 324.28M | 327.07M |
| Q2 FY2002 | 30 Jun 2002 | 679.85M | +112.43% | 325.25M | 354.60M |
| Q1 FY2002 | 31 Mar 2002 | 699.03M | +116.19% | 326.26M | 372.77M |
| Q4 FY2001 | 31 Dec 2001 | 743.20M | +91.25% | 327.61M | 415.60M |
| Q3 FY2001 | 30 Sept 2001 | 381.87M | -46.47% | 358.75M | 23.12M |
| Q2 FY2001 | 30 Jun 2001 | 320.03M | -15.42% | 348.65M | -28.62M |
| Q1 FY2001 | 31 Mar 2001 | 323.34M | -6.89% | 349.15M | -25.82M |
| Q4 FY2000 | 31 Dec 2000 | 388.60M | +1,133.65% | 362.34M | 26.26M |
| Q3 FY2000 | 30 Sept 2000 | 713.35M | +279.24% | 511.92M | 201.43M |
| Q2 FY2000 | 30 Jun 2000 | 378.39M | +3,278.44% | 180.82M | 197.56M |
| Q1 FY2000 | 31 Mar 2000 | 347.25M | +1,653.78% | 181.43M | 165.82M |
| Q4 FY1999 | 31 Dec 1999 | 31.50M | +30.17% | 7.06M | 24.44M |
| Q3 FY1999 | 30 Sept 1999 | 188.10M | +278.47% | 7.80M | 180.30M |
| Q2 FY1999 | 30 Jun 1999 | 11.20M | -69.15% | 8.40M | 2.80M |
| Q1 FY1999 | 31 Mar 1999 | 19.80M | -66.10% | 9.10M | 10.70M |
| Q4 FY1998 | 31 Dec 1998 | 24.20M | -66.15% | 9.80M | 14.40M |
| Q3 FY1998 | 30 Sept 1998 | 49.70M | -71.95% | 10.40M | 39.30M |
| Q2 FY1998 | 30 Jun 1998 | 36.30M | -80.75% | 9.60M | 26.70M |
| Q1 FY1998 | 31 Mar 1998 | 58.40M | -31.21% | 8.70M | 49.70M |
| Q4 FY1997 | 31 Dec 1997 | 71.50M | +104.87% | 8.40M | 63.10M |
| Q3 FY1997 | 30 Sept 1997 | 177.20M | +353.20% | 8.20M | 169.00M |
| Q2 FY1997 | 30 Jun 1997 | 188.60M | +1,927.96% | 8.20M | 180.40M |
| Q1 FY1997 | 31 Mar 1997 | 84.90M | +320.30% | 8.10M | 76.80M |
| Q4 FY1996 | 31 Dec 1996 | 34.90M | +22.89% | 8.50M | 26.40M |
| Q3 FY1996 | 30 Sept 1996 | 39.10M | -0.76% | 6.90M | 32.20M |
| Q2 FY1996 | 30 Jun 1996 | 9.30M | -78.91% | 6.90M | 2.40M |
| Q1 FY1996 | 31 Mar 1996 | 20.20M | -60.70% | 6.50M | 13.70M |
| Q4 FY1995 | 31 Dec 1995 | 28.40M | -60.34% | 7.00M | 21.40M |
| Q3 FY1995 | 30 Sept 1995 | 39.40M | -18.76% | 6.80M | 32.60M |
| Q2 FY1995 | 30 Jun 1995 | 44.10M | +107.04% | 6.90M | 37.20M |
| Q1 FY1995 | 31 Mar 1995 | 51.40M | -5.34% | 6.60M | 44.80M |
| Q4 FY1994 | 31 Dec 1994 | 71.60M | +150.35% | 6.40M | 65.20M |
| Q3 FY1994 | 30 Sept 1994 | 48.50M | +223.33% | 6.30M | 42.20M |
| Q2 FY1994 | 30 Jun 1994 | 21.30M | +227.69% | 6.00M | 15.30M |
| Q1 FY1994 | 31 Mar 1994 | 54.30M | +262.00% | 5.50M | 48.80M |
| Q4 FY1993 | 31 Dec 1993 | 28.60M | +146.55% | 6.00M | 22.60M |
| Q3 FY1993 | 30 Sept 1993 | 15.00M | -33.92% | 5.90M | 9.10M |
| Q2 FY1993 | 30 Jun 1993 | 6.50M | -60.12% | 5.90M | 600.00K |
| Q1 FY1993 | 31 Mar 1993 | 15.00M | -39.52% | 5.30M | 9.70M |
| Q4 FY1992 | 31 Dec 1992 | 11.60M | -57.97% | 5.10M | 6.50M |
| Q3 FY1992 | 30 Sept 1992 | 22.70M | +206.76% | 5.00M | 17.70M |
| Q2 FY1992 | 30 Jun 1992 | 16.30M | +608.70% | 4.40M | 11.90M |
| Q1 FY1992 | 31 Mar 1992 | 24.80M | — | 3.60M | 21.20M |
| Q4 FY1991 | 31 Dec 1991 | 27.60M | +527.27% | 3.30M | 24.30M |
| Q3 FY1991 | 30 Sept 1991 | 7.40M | — | 3.50M | 3.90M |
| Q2 FY1991 | 30 Jun 1991 | 2.30M | — | 3.50M | -1.20M |
| Q4 FY1990 | 31 Dec 1990 | 4.40M | — | 3.20M | 1.20M |
Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet
Common questions about Vertex Pharmaceuticals's cash
Source: Financial Modeling Prep